The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
Mahgoub, A., Dring, L. G., Idle, J. R., Lancaster, R., & Smith, R. L. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91430-1 · Cited by 1,183
Genetic Control of Isoniazid Metabolism in Man
Evans, D. A. P., Manley, K. A., & McKusick, V. A. (1960) · BMJ · doi:10.1136/bmj.2.5197.485 · Cited by 784
Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
Eichelbaum, M., Spannbrucker, N., Steincke, B., & Dengler, H. J. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562059 · Cited by 632
Evans, D. A., Mahgoub, A., Sloan, T. P., Idle, J. R., & Smith, R. L. (1980) · Journal of Medical Genetics · doi:10.1136/jmg.17.2.102 · Cited by 536
Schmid, B., Bircher, J., Preisig, R., & Küpfer, A. (1985) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1985.235 · Cited by 383
Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man
K�pfer, A., & Preisig, R. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00541938 · Cited by 362
Clinical significance of the sparteine/debrisoquine oxidation polymorphism
Br�sen, K., & Gram, L. F. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00637732 · Cited by 282
Methodology in medical genetics
Emery, A. E. H. (1976) · Cited by 266
Skoda, R. C., Gonzalez, F. J., Demierre, A., & Meyer, U. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5240 · Cited by 195
Topics in pharmaceutical sciences 1985
Park, K. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90025-3 · Cited by 184
Metoprolol metabolism and debrisoquine oxidation polymorphism‐ population and family studies.
McGourty, J. C., Silas, J., Lennard, M., et al. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb05112.x · Cited by 155
Polymorphic debrisoquin hydroxylation in 757 Swedish subjects
Steiner, E., Bertilsson, L., Säwe, J., Bertling, I., & Sjöqvist, F. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.176 · Cited by 133
Sanz, E. J., Villén, T., Alm, C., et al. (1989) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1989.63 · Cited by 116
Balanced Pharmacokinetics and Metabolism of Bisoprolol
Leopold, G. (1985) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198511001-00003 · Cited by 88
Phenotyping polymorphic drug metabolism in the French Caucasian population
Jacqz, E., Dulac, H., & Mathieu, H. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609247 · Cited by 74
Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices.
Jackson, P., Tucker, G., Lennard, M., & Woods, H. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb02933.x · Cited by 66
Polymorphism of dextromethorphan oxidation in a French population.
Larrey, D. G., Amouyal, G., Tinel, M., Lettéron, P., Berson, A., Labbe, G., & Pessayre, D. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03230.x · Cited by 49
ENZYME DIVERSITY IN HUMAN POPULATIONS
Harris, H., Hopkinson, D. A., & Luffman, J. E. (1968) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1968.tb11893.x · Cited by 35
Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark.
Drohse, A., Bathum, L., Brøsen, K., et al. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03426.x · Cited by 32
Cited by
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
Desta, Z., Zhao, X., Shin, J.-G., & Flockhart, D. A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241120-00002 · Cited by 942
Inhibition and Induction of Cytochrome P450 and the Clinical Implications
Lin, J. H., & Lu, A. Y. H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00003 · Cited by 829
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part I
Zhou, S.-F. (2009) · Clinical Pharmacokinetics · doi:10.2165/11318030-000000000-00000 · Cited by 756
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
Lin, J. H., & Lu, A. Y. H. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01340-1 · Cited by 708
Metadata
- Authors
- Alv�n, G., Bechtel, P., Iselius, L., & Gundert-Remy, U.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 1990-12
- Volume
- 39
- Issue
- 6
- Pages
- 533-537
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2111731642
- Cited by
- 361
- References
- 19
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.